add

Tuesday, February 26, 2019

Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Google to Host The Android Show Ahead of I/O 2026 Developer Conference Next Week

Google announced the date for The Android Show: I/O Edition on Tuesday. The second edition of the virtual-only event will take place on May ...